Cary Street Partners’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Sell
1,402
-27
-2% -$2.51K ﹤0.01% 980
2026
Q1
$139K Sell
1,429
-3,869
-73% -$354K ﹤0.01% 880
2025
Q4
$468K Buy
5,298
+4,131
+354% +$376K 0.01% 614
2025
Q3
$105K Buy
1,167
+396
+51% +$32.1K ﹤0.01% 861
2025
Q2
$58.4K Buy
771
+339
+78% +$25.2K ﹤0.01% 861
2025
Q1
$30.8K Sell
432
-209
-33% -$16.3K ﹤0.01% 833
2024
Q4
$56.2K Buy
+641
New +$56.1K ﹤0.01% 792

Other funds holding SRE

Cary Street Partners's SRE Position: Q2 2026 in Review

Cary Street Partners reduced its Sempra (SRE) stake by 1.9% in Q2 2026, selling an estimated $2.51K and leaving 1,402 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Cary Street Partners first reported a position in SRE in Q4 2024 and has held it in 7 quarters since. The position peaked at $468K in Q4 2025. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Cary Street Partners held 1,402 shares of Sempra worth $130K as of Q2 2026.
  • Cary Street Partners sold 27 Sempra shares in Q2 2026, an estimated $2.51K.
  • Sempra made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #980 holding.
  • Cary Street Partners first reported a position in Sempra in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Sempra position peaked at $468K in Q4 2025.
  • 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.